Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (GU5) — Defensive Interval Ratio

Latest as of March 2026: 178 days

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (GU5) has a Defensive Interval Ratio of 178 days as of March 2026. Defensive assets of €19.90 Billion (cash €-, short-term investments €4.00 Million, receivables €19.90 Billion) cover 178 days of daily cash needs of €111.68 Million/day. Check Guangzhou Baiyunshan Pharmaceutical Hold tangible book value ratio to evaluate the tangible quality of the company's equity base.

Defensive Interval Ratio

178 days
Days of operational coverage

Defensive Assets

€19.90 Billion
Cash + ST Investments + Receivables

Daily Cash Need

€111.68 Million
Current Liabilities ÷ 365

Current Liabilities

€40.76 Billion
EUR

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Defensive Interval Ratio (2013–2025)

This chart shows how Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited's Defensive Interval Ratio has evolved across 13 annual periods from 2013 to 2025. As of March 2026, the ratio stands at 178 days, meaning defensive assets of €19.90 Billion can fund 178 days of operations without new revenue. Also explore Guangzhou Baiyunshan Pharmaceutical Hold annual equity growth to track the company's year-over-year net asset growth rate.

Annual Defensive Interval Ratio for Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (2013–2025)

The table below presents the year-by-year Defensive Interval Ratio for Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited from 2013 to 2025, covering 13 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see market value of Guangzhou Baiyunshan Pharmaceutical Hold.

Year DIR (days) Defensive Assets (EUR) Daily Cash Need Cash ST Investments Change (days)
2025 157 days €16.85 Billion €107.19 Million/day €- €4.00 Million ▲ +10 days
2024 147 days €15.73 Billion €106.62 Million/day €- €- ▼ -5 days
2023 152 days €15.12 Billion €99.27 Million/day €- €4.00 Million ▲ +7 days
2022 146 days €14.91 Billion €102.45 Million/day €- €56.87 Million ▲ +1 days
2021 145 days €12.82 Billion €88.37 Million/day €- €- ▼ -10 days
2020 155 days €12.39 Billion €80.12 Million/day €- €4.00 Million ▼ -54 days
2019 208 days €16.77 Billion €80.48 Million/day €- €- ▼ -12 days
2018 220 days €16.25 Billion €73.83 Million/day €- €1.54 Billion ▲ +66 days
2017 154 days €3.50 Billion €22.65 Million/day €- €4.88 Million ▲ +12 days
2016 142 days €2.89 Billion €20.34 Million/day €- €6.03 Million ▼ -1 days
2015 143 days €2.68 Billion €18.71 Million/day €- €43.19 Million ▼ -14 days
2014 157 days €2.62 Billion €16.65 Million/day €- €- ▼ -18 days
2013 175 days €2.42 Billion €13.84 Million/day €- €- —
DIR = (Cash + Short-term Investments + Net Receivables) / (Daily Cash Expenses)